Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03449927 · ClinicalTrials.gov registry record · Phase 1
Implementation of a Nutritional Tool During Melphalan Autologous Transplant to Improve Caloric and Protein Intake
A Phase 1 study of Melphalan Autologous Transplant, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03449927 is a Phase 1 study of Melphalan Autologous Transplant that has completed, run by Washington University School of Medicine. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03449927, a Phase 1 study of Melphalan Autologous Transplant, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot before and after interventional study is to determine if early intervention and provision of menus regarding appropriate diet choices for melphalan autologous transplant patients experiencing nausea and diarrhea will improve nutrition status and overall calorie and protein intake throughout the transplant process.
Conditions Studied
Interventions
- OTHER Specialized menu
- OTHER Standard of care menu
- OTHER Self report dietary intake worksheet
- OTHER Post study questionnaire
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2018-02-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03449927
The ClinicalTrials.gov registry entry for NCT03449927 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Melphalan Autologous Transplant appearing as the primary indexed condition, and to 4 interventions - of which Specialized menu is the first listed.
NCT03449927 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT03449927 about?
NCT03449927 is a clinical study titled "Implementation of a Nutritional Tool During Melphalan Autologous Transplant to Improve Caloric and Protein Intake". The purpose of this pilot before and after interventional study is to determine if early intervention and provision of menus regarding appropriate diet choices for melphalan autologous transplant patients experiencing nausea and diarrhea will improve nutrition status and overall calorie and protein ...
What is the current status of trial NCT03449927?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2018-01-01. Estimated completion is 2018-02-27.
What conditions does trial NCT03449927 study?
This clinical trial studies the following conditions: Melphalan Autologous Transplant.
What interventions are being tested in trial NCT03449927?
The interventions under investigation include: Specialized menu (OTHER), Standard of care menu (OTHER), Self report dietary intake worksheet (OTHER), Post study questionnaire (OTHER).
Who is sponsoring clinical trial NCT03449927?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03449927 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.